David E. Martin talk in the 3rd International Covid Summit | European Union May 2023. I stand with Dr. Martin By Professor Ian Brighthope

       1. The central proposition

Dr David Martin presents COVID-19 not as an unexpected natural emergency but as the culmination of decades of coronavirus research, patenting, commercial planning and biological manipulation.

His principal argument is that the history of coronavirus research must be examined as a continuous process extending back to the 1960s. In his account, the pandemic response cannot be properly understood by beginning with the Wuhan outbreak in late 2019. He believes its origins lie in the earlier transformation of naturally occurring coronaviruses into research tools, patented biological materials, vaccine targets and, eventually, potential biowarfare platforms.

Dr. Martin's speech is therefore not primarily about the clinical management of COVID-19. It is an accusation against a system comprising government agencies, research institutions, pharmaceutical corporations, military and biodefence programmes, patent authorities and investors.

2. His warning about biological patents

Dr. Martin begins by recalling an earlier appearance before the European Parliament, when he opposed adopting the American practice of granting patents over biologically derived materials.

He characterises biological patenting as the beginning of a process through which nature was appropriated for private and strategic purposes. Once elements of living organisms could be treated as intellectual property, he argues, corporations and institutions acquired a financial incentive to manipulate pathogens, diagnostic processes and medical countermeasures.

His central moral concern is that living biological systems were transformed from shared features of nature into privately controlled commercial and strategic assets.

3. The historical timeline

Dr. Martin constructs a timeline intended to show that coronavirus research was neither recent nor improvised:

In 1965, human coronavirus was identified and isolated in association with the common cold.

In 1966, coronavirus material was reportedly exchanged between researchers in the United States and the United Kingdom.

In 1967, researchers conducted human challenge experiments involving coronavirus.

During the 1970s, coronavirus research expanded into animal models, including dogs and pigs.

By 1990, veterinary coronavirus had become an important commercial problem.

In 1990, Pfizer-related research allegedly produced an early coronavirus spike-protein vaccine patent.

Between 1999 and 2002, NIAID-financed coronavirus research was undertaken at the University of North Carolina.

In 2002, UNC patented an "infectious, replication-defective clone" of coronavirus.

In 2003, the CDC applied for patents connected with the SARS coronavirus.

From 2005 onwards, Dr. Martin says coronavirus was discussed as a potential bioterrorism or biological-warfare platform.

In 2014, certain coronavirus research reportedly received an exemption from the US pause on gain-of-function work.

In 2015–2016, researchers published work demonstrating that SARS-like bat coronaviruses could infect human cells and had the potential for human emergence.

During 2017–2019, pandemic-preparedness discussions increasingly contemplated an accidental or intentional release of a respiratory pathogen.

In 2019, Moderna patent language allegedly referred to such a release before the recognised emergence of COVID-19.

By 2020, Dr. Martin argues, coronavirus had provided the justification for worldwide adoption of a new vaccine platform.

Through this chronology, Dr.Martin attempts to replace the narrative of a sudden emergency with one of long-term institutional planning and technological development.

4. Coronavirus vaccine research

Dr. Martin maintains that researchers had known for decades that coronaviruses mutate and evolve in ways that make durable vaccination difficult. He argues that the scientific literature between 1990 and 2018 repeatedly documented problems including viral mutation, antigenic change and vaccine escape.

From this, he draws a much broader conclusion: that authorities already knew coronavirus vaccines could not reliably provide lasting protection, yet presented the COVID-19 products as though they represented a new and decisive solution.

This is one of the speech's sweeping claims. Coronavirus-vaccine performance varies by virus, vaccine design and outcome measured. COVID-19 vaccines, for example, have shown substantially stronger protection against severe disease than against infection, particularly after new variants emerged. Dr. Martin does not explore these distinctions; instead, he treats limitations identified in earlier coronavirus-vaccine research as evidence against the entire programme.

5. The 2002 UNC patent

A critical point in Dr. Martin's argument is the University of North Carolina patent describing an "infectious, replication-defective" coronavirus clone.

Dr. Martin interprets this terminology as evidence of weapons development. He contends that an infectious but replication-defective construct is intended to affect a target while limiting uncontrolled spread.

Scientifically, however, replication-defective viral constructs are also routinely developed for research, vaccine delivery and gene-transfer applications because their inability to reproduce normally may improve safety. The words alone do not establish that a construct is a weapon. Dr. Martin's conclusion therefore depends upon his interpretation of the patent's purpose, funding and historical context rather than upon the quoted phrase by itself.

He nevertheless uses this patent as the foundation for his assertion that SARS was engineered and that relevant work preceded the recognised 2002–2003 outbreak.

6. SARS and the CDC patents

Dr. Martin alleges that SARS was not a natural event but the product of human engineering. He points to the timing of UNC research and subsequent CDC patent applications as evidence.

He further accuses the CDC of improperly patenting a viral sequence obtained from China and claims that the application was initially rejected before institutional influence caused the patent to be granted.

The speech treats the existence of patents as evidence of ownership, control and potentially prior knowledge. However, patents on isolated sequences, diagnostic tests and research tools do not in themselves prove that the patent holder created or released the underlying pathogen. Establishing that conclusion would require genomic, documentary and forensic evidence beyond patent chronology.

7. Gain-of-function research

Dr. Martin strongly condemns gain-of-function research, particularly experiments designed to alter viral infectivity, host range or pathogenic characteristics.

He alleges that the 2014 US moratorium was undermined by exemptions allowing coronavirus research at UNC to continue. He connects this work to research involving Ralph Baric, the Wuhan Institute of Virology and the WIV1 coronavirus.

In Dr.Martin's interpretation, the published description of SARS-like viruses as "poised for human emergence" did not merely warn of a natural zoonotic risk. It revealed that researchers had produced or characterised viruses capable of infecting humans.

This leads to his first major policy demand: an absolute prohibition on gain-of-function research.

8. "Accidental or intentional release"

Dr.Martin places considerable emphasis on the expression "accidental or intentional release of a respiratory pathogen." He argues that its appearance in scientific discussions, preparedness exercises and patent documents before COVID-19 demonstrates anticipation of a release event.

He treats the term "release" as evidence that officials and corporations contemplated a laboratory or deliberate origin rather than purely natural spillover.

He then goes further, arguing that the appearance of this language in Moderna patent applications during 2019 indicates planning for a future vaccine market.

The chronology may justify investigating what institutions anticipated and why, but anticipation of a pandemic does not by itself demonstrate responsibility for causing one. Preparedness documents commonly consider hypothetical accidental, deliberate and naturally occurring biological events. Dr. Martin interprets those preparations as evidence of foreknowledge and premeditation.

9. The universal vaccine platform

Dr. Martin contends that an overriding institutional objective was to secure public acceptance of a universal vaccine platform.

Under his interpretation, coronavirus provided the ideal mechanism:

1.Create or amplify fear of a rapidly spreading respiratory pathogen.

2.Declare a global emergency.

3.use media attention to generate demand for medical countermeasures.

4.Introduce a rapidly adaptable vaccine platform.

5.Ensure government purchasing and public uptake.

6.Create sustained commercial returns for investors.

He regards the pandemic not simply as a health emergency exploited after the fact, but as the instrument through which a pre-existing technological and commercial objective was achieved.

10. The role of media and investment

One of Dr. Martin's most powerful rhetorical moments is his recitation of comments attributed to a pandemic-preparedness discussion. The statement describes infectious-disease crises as receiving insufficient attention until they become immediate emergencies. It then discusses media attention, commercial incentives and investor interest.

Dr. Martin interprets the language about media "hype" and investor profit as an admission that fear would be used to create a market.

A less accusatory interpretation would be that developers of broadly protective vaccines struggle to obtain funding between outbreaks and were discussing how to maintain investment in preparedness. Dr.Martin rejects that interpretation. To him, the language exposes a system in which public fear, media promotion and private profit were deliberately connected.

11. Allegations against Fauci, NIAID and biodefence agencies

Dr. Martin accuses Anthony Fauci and NIAID of financing coronavirus research that crossed the boundary between public health and biological weapons development.

He claims that billions of dollars flowed through biodefence or classified programmes operating beside the publicly visible research budget. He argues that concentrating only on EcoHealth Alliance, DARPA or the Wuhan laboratory conceals the broader American institutional and financial network behind coronavirus research.

The speech presents this as a coordinated structure rather than a collection of independent research programmes. Dr. Martin does not provide the underlying accounting records in the transcript, so his specific claim of a matching, dollar-for-dollar clandestine balance sheet would require separate documentary verification.

12. "Nature was hijacked"

Dr. Martin concludes that nature itself was hijacked when scientists began modifying naturally occurring coronavirus systems for institutional, military and commercial purposes.

This is both a scientific and philosophical argument. He believes humanity crossed an ethical boundary by treating nature as a platform to be engineered, patented and monetised without adequate consideration of the consequences.

His concern is not limited to the possibility of a laboratory accident. He rejects the underlying presumption that scientists and corporations have the moral right to redesign potentially dangerous organisms.

13. "Science was hijacked"

His second conclusion is that science was captured by patent ownership, government funding and corporate interest.

Dr. Martin argues that the research questions permitted to receive funding were those compatible with the intellectual-property portfolios and strategic interests of agencies such as the CDC, FDA and NIH and their counterparts in other countries.

According to this argument, research may retain the outward form of science while losing genuine independence. Funding priorities, publication decisions, commercial partnerships and regulatory policy can define which questions are studied and which conclusions become institutionally acceptable.

14. Failure of ethical oversight

Dr. Martin alleges that no genuinely independent, financially disinterested review body examined the entire coronavirus research programme.

He argues that institutional review boards examined isolated studies while failing to address the cumulative moral question: Should humanity be manipulating coronaviruses, creating chimeric organisms, patenting their components and developing technologies capable of both therapeutic and military use?

His underlying criticism is that procedural approval is not the same as moral legitimacy. A succession of individually approved experiments can, in his view, produce a profoundly dangerous programme without any body accepting responsibility for its overall direction.

15. Corporate liability

Dr. Martin's final recommendation is that corporations should not be permitted to finance, control or profit from scientific research while being shielded from responsibility for resulting harm.

He calls for pharmaceutical and biotechnology companies to accept complete liability for injuries and deaths associated with their products. He regards immunity from liability as an incentive for reckless behaviour because profits can be privatised while risks are transferred to governments and the public.

16. Doctor Martin's final demands

His speech culminates in three uncompromising demands:

End gain-of-function research.

End the weaponisation of natural biological systems.

End corporate control of science unless corporations accept full responsibility for harms caused by their products.

Overall assessment

Dr Martin's speech is a forceful historical indictment of the institutions involved in coronavirus research and pandemic preparedness. Its greatest strength is its insistence that COVID-19 be examined within the longer history of biological patents, biodefence funding, gain-of-function research, pharmaceutical incentives and inadequate accountability.

However, the speech frequently moves from documented facts—such as the existence of patents, research programmes and preparedness discussions—to conclusions that those facts alone do not conclusively establish. Patent filings do not by themselves prove pathogen creation or release; preparedness for a possible biological event does not necessarily prove foreknowledge; and "replication-defective" is not synonymous with "biological weapon."

Consequently, Dr.Martin's presentation is best understood as a prosecutorial thesis: it assembles a chronology and interprets it as evidence of coordinated premeditation, financial exploitation and biological warfare. Some elements of the chronology are verifiable, while his most serious conclusions require considerably more direct evidence than is presented in the transcript.

I STAND WITH DR DAVID MARTIN

I have listened carefully to Dr David Martin's address. I have considered the chronology he presents, the patents he identifies, the institutions he names and the questions he demands that the world confront.

My conclusion is unequivocal: I stand with Dr Martin.

I give him my wholehearted and unreserved support in demanding a full, independent and publicly accountable investigation into the origins of SARS-CoV-2, the history of coronavirus experimentation, gain-of-function research, biological patenting, biodefence funding and the immense commercial interests behind the COVID-19 response.

Dr Martin's critics describe his statements as "allegations," as though that word alone disposes of the evidence. It does not. An allegation supported by documents, patents, published papers, funding records and an identifiable chronology deserves investigation—not ridicule, censorship or institutional silence.

The proper response is not to attack the man. It is to examine the evidence.

If his chronology is wrong, let the responsible institutions release every relevant document and demonstrate precisely where it is wrong. If his interpretation of a patent is disputed, let the patent holders explain its purpose under oath. If the funding relationships have been misrepresented, open the books. If the research was entirely defensive and benevolent, release the laboratory records, grant applications, communications, genomic databases, risk assessments and minutes of ethical-review meetings.

Transparency would settle the matter. Secrecy perpetuates suspicion.

This did not begin in 2020

One of Dr Martin's most important contributions is his refusal to allow the history of COVID-19 to begin at a Wuhan market in December 2019. He places it within a much longer history of coronavirus isolation, experimentation, modification, patenting and commercial exploitation.

That broader history matters.

Coronavirus research reaches back to the 1960s. Human challenge experiments were undertaken decades ago. Coronaviruses were studied in animals, manipulated in laboratories and used as models for vaccine development. Spike-protein vaccine research did not suddenly materialise during Operation Warp Speed. The scientific, commercial and intellectual-property foundations had been developing for many years.

The public was sold an image of unprecedented scientific improvisation: a novel virus appeared, heroic institutions sprang into action and entirely new vaccines were miraculously created within months.

Dr Martin challenges that carefully cultivated impression. He argues that much of the platform, patent architecture and commercial strategy existed long before the declared emergency. That contention must be examined fully and fearlessly.

Patents are not incidental

We are told that biological patents are merely administrative instruments protecting scientific innovation. That explanation is inadequate.

Patents establish ownership, commercial control and potential profit. They can reveal what institutions were developing, what applications they contemplated and when they possessed relevant knowledge.

A patent does not, by itself, prove that its owner released a pathogen or committed a crime. But neither should it be dismissed as meaningless. When patents, research programmes, government grants, military interests and commercial products form an interconnected chronology, they become legitimate evidence requiring forensic examination.

Dr Martin has placed that chronology before the public. The institutions involved must now answer it point by point.

Who financed the research?

What precisely was created?

Why was it created?

Who owned the resulting intellectual property?

What risks were identified?

What warnings were ignored?

What commercial opportunities were anticipated?

Which experiments continued during the supposed gain-of-function moratorium?

Who granted exemptions, and on what authority?

These are not conspiracy questions. They are elementary questions of scientific governance, biosecurity and public accountability.

Gain-of-function research must end

On the central moral question, I believe Dr Martin is right: humanity must stop engineering potentially pandemic pathogens.

We have been assured that gain-of-function research is necessary to anticipate future outbreaks. But creating enhanced threats in order to protect ourselves against enhanced threats is a dangerously circular proposition. It asks humanity to accept the possibility of catastrophic accident, misuse or deliberate release in exchange for speculative future benefits.

No laboratory is infallible. No security system is impenetrable. No researcher is incapable of error. No government can guarantee that dangerous knowledge or biological material will never be stolen, transferred or weaponised.

The risk is not confined to one country. Whether such work is conducted in Wuhan, North Carolina or anywhere else, an engineered pathogen does not respect borders, treaties or institutional reputations.

If a line of research could cause a global catastrophe through a single failure, humanity has every right to prohibit it.

That is not anti-science. It is science governed by ethics, humility and survival.

The conflict between public health and profit

Dr Martin also directs attention to an uncomfortable question: what happens when pandemic preparedness becomes a commercial opportunity?

There is an unavoidable conflict when the organisations helping to define a threat also finance the research, own relevant patents, develop the proposed solution, influence regulators and profit from government purchasing.

The COVID-19 emergency produced extraordinary financial rewards. Public money underwrote research and purchasing, governments guaranteed markets, manufacturers received exceptional legal protections, and billions of people were subjected to unprecedented pressure to accept newly deployed products.

Meanwhile, dissenting doctors were threatened, suspended, censored and publicly vilified. Patients reporting serious injuries were ignored or dismissed. Legitimate scientific disagreement was reduced to "misinformation." Regulatory bodies behaved less like independent guardians and more like enforcers of an authorised narrative.

This was not how ethical medicine should operate.

Science does not require censorship. Truth does not fear questions. A safe and effective product does not need coercion, career destruction, digital surveillance or the silencing of injured patients to defend it.

The media must answer for its conduct

Dr Martin identifies the media as an essential part of the pandemic machinery. I agree.

Much of the media abandoned investigation at the moment investigation was most urgently needed. Instead of interrogating governments, pharmaceutical companies, regulators and research institutions, many journalists amplified their talking points.

The media repeated "safe and effective" as though repetition were evidence. It stigmatised disagreement. It encouraged social hostility against people who exercised their right to refuse a medical intervention. It rarely investigated conflicts of interest, legal indemnities, changing efficacy claims, suppressed treatment options or the experiences of vaccine-injured people.

When scientific uncertainty was greatest, the media projected absolute certainty. When scrutiny was most necessary, it promoted conformity.

This failure must be included in any genuine inquiry into the COVID era.

An independent investigation is indispensable

The institutions implicated in these questions cannot be allowed to investigate themselves.

We need an international, independent and legally empowered inquiry with no financial relationship to pharmaceutical manufacturers, vaccine-promotion organisations, implicated research institutions, the WHO or national agencies involved in funding and regulating the relevant research.

Such an inquiry must have the authority to obtain:

complete patent histories and associated correspondence;

grant applications and funding records;

laboratory notebooks and genomic databases;

communications between researchers and government officials;

biodefence and military contracts;

gain-of-function exemptions and risk assessments;

communications involving pharmaceutical manufacturers;

regulatory submissions and pharmacovigilance data;

pandemic-simulation documents;

evidence concerning vaccine injuries and excess mortality;

records relating to censorship and the suppression of scientific dissent.

Witnesses must testify under oath. Documentary evidence must be preserved. Conflicts of interest must be publicly declared. Whistleblowers must receive legal protection.

If no wrongdoing occurred, transparency will vindicate the institutions concerned. If wrongdoing did occur, those responsible must face justice.

Nature, science and medicine were captured

Dr Martin says nature was hijacked. I understand exactly what he means.

Nature was treated as raw material for manipulation.

Science was subordinated to funding, patents and institutional ambition.

Medicine was converted from a covenant between doctor and patient into an instrument of policy enforcement.

Public health became entangled with surveillance, censorship, political coercion and corporate profit.

The sacred principles of informed consent, bodily autonomy and primum non nocere—first, do no harm—were pushed aside.

This must never be permitted to happen again.

Full liability must be restored

I strongly support Dr Martin's demand for corporate accountability.

No corporation should profit from a medical product while transferring the cost of injury to patients and taxpayers. No manufacturer should enjoy extraordinary legal protection while injured people struggle for recognition, treatment and compensation.

If pharmaceutical companies insist that their products are safe, they should be prepared to stand behind them.

Full liability creates discipline. Immunity creates moral hazard.

Every patient harmed by a medical intervention deserves acknowledgement, investigation, treatment and fair compensation. Human suffering must never be dismissed as an acceptable statistical inconvenience.

My position is clear

I stand 100 per cent with Dr David Martin in his demand that these matters be exposed to independent examination.

That does not mean declaring every disputed inference legally proven before an investigation has occurred. It means refusing to use uncertainty as an excuse for silence. It means recognising that his documentary chronology raises questions too serious to dismiss and allegations too grave to leave unanswered.

Dr Martin has shown courage in naming institutions that possess enormous political, financial and media power. His arguments deserve to be confronted with documents and sworn evidence—not censorship, mockery or character assassination.

The world cannot heal while the truth remains buried.

We need an immediate global prohibition on dangerous gain-of-function experimentation. We need complete transparency surrounding biological patents and biodefence research. We need the restoration of scientific independence, medical ethics, informed consent and corporate liability. We need justice for those injured, bereaved, silenced and abandoned.

Above all, we need the courage to ask what happened, who knew, who benefited and who must be held accountable.

I support Dr David Martin because these questions concern the survival of ethical medicine and the future of humanity itself.

No more secrecy.

No more censorship.

No more weaponisation of nature.

No more science without conscience.

No more profit without responsibility.

And no more silence.

Ian Brighthope